Welcome to our dedicated page for Agilon Health news (Ticker: AGL), a resource for investors and traders seeking the latest updates and insights on Agilon Health stock.
The agilon health, inc. (AGL) news page on Stock Titan aggregates company-specific updates for investors and observers who follow its role in value-based healthcare. agilon health describes itself as a trusted partner empowering physicians to transform health care in their communities, and its news flow reflects this focus on physician partnerships and senior care.
Company announcements commonly cover financial results, including quarterly earnings releases that discuss membership on the agilon platform, revenue from medical services, and performance within its value-based care arrangements. These releases often provide detail on metrics related to Medicare Advantage members and other value-based models for senior patients.
agilon health news also includes items on leadership and governance, such as changes in executive roles, the establishment of an Office of the Chairman, and updates on board-level decisions. In addition, the company frequently announces participation in healthcare and investor conferences, where its management team discusses the business, its Total Care Model, and its value-based care strategy.
Another recurring theme in agilon health’s news is research related to value-based care. The company has highlighted studies examining how its model may relate to clinical and quality outcomes, healthcare utilization, and access to primary care for Medicare patients. These research-focused releases describe how physicians working within agilon’s value-based care framework manage senior patients and how payment models may influence practice patterns.
Visitors to this page can review these types of updates in one place, from earnings announcements and NYSE compliance notices to conference appearances and research publications connected to agilon health’s value-based Total Care Model for senior patients.
agilon health (NYSE: AGL) announced its participation in Bernstein's 41st Annual Strategic Decisions Conference. The company will deliver a fireside chat presentation on Wednesday, May 28 at 4:30 PM Eastern Time. Investors can access the live webcast through agilon's investor relations website at investors.agilonhealth.com, with on-demand replays available shortly after the presentation.
agilon health (NYSE: AGL) reported its Q1 2025 financial results, showing a mixed performance with some declines but improved profitability. The company posted total revenues of $1.53 billion, down 4% from Q1 2024. Total platform members decreased to 605,000, including 491,000 Medicare Advantage members and 114,000 ACO REACH beneficiaries, reflecting previously disclosed market exits.
The company achieved net income of $12 million in Q1 2025, compared to a net loss of $6 million in Q1 2024. Medical margin was $128 million, down from $157 million, while Adjusted EBITDA decreased to $21 million from $29 million. The company maintains a strong capital position with $369 million in cash and equivalents and $35 million in total debt.
agilon health reaffirmed its full-year 2025 guidance, projecting total revenues between $5.85-6.025 billion and expects medical cost trends of 6.3% gross and 5.3% net for year 2+ markets.
agilon health (NYSE: AGL) has announced its participation in the upcoming BofA Securities 2025 Health Care Conference. The company will deliver a fireside chat presentation on Wednesday, May 14 at 1:00 PM Eastern Time.
Investors and interested parties can access the presentation through a simultaneous webcast available on the 'Events & Presentations' section of agilon health's investor relations website. On-demand replay options will be made available shortly after the presentation concludes.
agilon health (NYSE: AGL) has scheduled the release of its first quarter 2025 financial results after market close on Tuesday, May 6, 2025. The company will host a conference call at 4:30 PM Eastern Time on the same day to discuss the results.
U.S. participants can join the call by dialing (833) 470-1428, while international participants can dial +1 (404) 975-4839, using participant code 095319. A simultaneous webcast will be available through the 'Events & Presentations' section of agilon's Investor Relations website. An on-demand replay will be accessible shortly after the call concludes.
agilon health (NYSE: AGL) reported its Q4 and full-year 2024 results, showing significant membership growth but facing financial challenges. Total revenue increased 44% to $1.52 billion in Q4 2024, while full-year revenue grew 40% to $6.06 billion.
Medicare Advantage membership rose 36% year-over-year to 527,000 members, with total platform members reaching 659,000. However, the company faced profitability challenges with a Q4 gross profit of negative $38 million and a net loss of $106 million.
For 2025, agilon expects approximately 20,000 new Medicare Advantage members from Class of 2025, while planning to exit partnerships affecting 54,000 members. The company projects continued elevated medical cost trends, with an estimated gross cost trend of 6.3% and 5.3% net for year 2+ markets.
agilon health (NYSE: AGL) has announced its participation in the 45th Annual TD Cowen Healthcare Conference. The company will deliver a fireside chat presentation on Wednesday, March 5 at 9:50 AM Eastern Time.
Investors and interested parties can access a simultaneous webcast of the presentation through the 'Events & Presentations' section on agilon health's investor relations website. The presentation will also be available for on-demand replay shortly after its completion.
agilon health (NYSE: AGL) has announced it will release its fourth quarter and full year 2024 financial results after market close on Tuesday, February 25, 2025. The company will host a conference call at 4:30 PM Eastern Time on the same day to discuss the results.
Participants can join the conference call by dialing (833) 470-1428 (U.S.) or +1 (404) 975-4839 (international) using participant code 599648. A simultaneous webcast will be available through the 'Events & Presentations' section of agilon's Investor Relations website. An on-demand replay will be accessible shortly after the call concludes.
agilon health (NYSE: AGL) announced significant achievements in its ACO REACH model for 2023. The company's eight Accountable Care Organizations (ACOs) generated $150 million in gross savings (13% gross savings rate), including $37 million in Medicare Trust Fund savings. Operating under full risk for approximately 90,000 Traditional Medicare beneficiaries, the ACOs achieved an impressive 95% average quality score, with four ACOs reaching 100%. Five ACOs earned High Performers Pool status, securing an additional $7 million bonus. Since 2021, agilon's REACH ACOs have accumulated $281 million in gross savings, with $71 million benefiting the Medicare Trust Fund.
agilon health reported Q3 2024 results with revenue increasing 28% to $1.45 billion. Medicare Advantage membership grew 37% to 525,000, while total platform members increased 39% to 657,000. The quarter was impacted by challenges including $60 million in prior year development costs, $65 million reduction in 2024 risk adjustment, and $25 million in higher medical expenses. The company reported a gross profit loss of $64 million and a net loss of $118 million. In response, agilon plans to exit two unprofitable partnerships and certain payor contracts by end of 2024. The company updated its full-year 2024 guidance, reflecting Q3 results and revised Q4 cost trends.
agilon health (NYSE: AGL) has announced its participation in the 2024 Wolfe Research Healthcare Conference. The company will deliver a fireside chat presentation on Tuesday, November 19, at 2:20 PM Eastern Time.
Interested parties can access a live webcast of the event through the 'Events & Presentations' section of agilon's Investor Relations website. On-demand replay of the conference will be made available shortly after the completion of each call.
FAQ
What is the current stock price of Agilon Health (AGL)?
What is the market cap of Agilon Health (AGL)?
